ConsumerAffairs18h
Compounding pharmacies can keep making Mounjaro and Zepbound copies
The U.S. Food and Drug Administration (FDA) is rethinking its decision to remove popular weight-loss and diabetes drugs from ...
Which clot-busting drug is tied to better recovery after stroke?
For people with ischemic stroke, treatment with the clot-busting drug tenecteplase is associated with a slightly higher ...
Health.com1d
What the End of a Tirzepatide Shortage Would Mean for Access to Compounded Weight Loss Drugs
In response to a lawsuit, the FDA has said that it will reevaluate its previous decision to remove tirzepatide from its ...
Zacks.com on MSN1d
Exelixis Gets Favorable Ruling in Patent Litigation With MSN
Exelixis, Inc. EXEL announced that the District Court of Delaware has ruled in its favor in the second patent litigation ...
Daily1d
Abbott's review plea challenging NPPA ceiling price fixation of 18 formulations rejected by DoP
The Department of Pharmaceuticals (DoP) has dismissed two review applications filed by Abbott Healthcare Private Limited ...
Eli Lilly's tirzepatide is off the FDA's shortage list: What it means for patients
Eli Lilly's weight-loss drug is no longer on the Food and Drug Administration's drug shortage list. Compounding pharmacies say this will limit patient access.
The Financial Express3d
11 countries already recognise Indian pharmacopoeia as their standard: DCGI
India has been declared 'functional' against all the core regulatory functions of the WHO Global Benchmarking Tool Version VI ...
ndtvprofit6d
Cipla Share Price Falls After Chinese Rival Eats Into Cancer Drug Opportunity
While Citi has maintained its 'buy' call for Cipla, it noted that a further delay in resolving issues at the Goa facility ...